相关实验视频
Updated: Sep 10, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.8K
预测计算框架为个性化心血管医学提供数字双胞胎
Mengzhe Lyu1,2, Ryo Torii3, Ce Liang4
1Department of Mechanical Engineering, University College London, London, UK. ucemmly@ucl.ac.uk.
Communications medicine
|August 25, 2025
概括
一种新的虚拟冠状动脉干预 (VCI) 技术可非侵入性地预测穿皮冠状动脉干预 (PCI) 的术后结果. 这种VCI模型显示了优化PCI规划,提高程序安全性和效率的潜力.
科学领域:
- 心血管研究
- 医学成像分析
- 介入性心脏病学
背景情况:
- 穿皮冠状动脉干预 (PCI) 需要精确的计划以获得最佳结果.
- 目前用于定量模拟冠状动脉干预的方法缺乏高精度和有效性.
- 精确预测PCI后的分流储量 (FFR) 和血管解剖学是至关重要的.
研究的目的:
- 开发和验证虚拟冠状动脉干预 (VCI) 技术.
- 为PCI规划提供非侵入性生理和解剖学评估.
- 量化模拟冠状动脉干预结果.
主要方法:
- 参与该试验的患者有严重的冠状动脉病变 (PCI前CT-FFR< 0. 80).
- 使用VCI框架预测血管重塑和PCI后CT-FFR.
- 根据PCICT血管图的数据,验证了预测VCICT-FFR,光线横截面 (CSA) 和中线曲率.
主要成果:
- VCI模拟时间平均为24.92秒.
- 预测的VCI后CT-FFR (0.90 ± 0.08) 与PCI后CT-FFR (0.92 ± 0.09) 非常相匹配.
- 形态预测 (CSA,中线曲率) 与PCI后的测量结果一致.
结论:
- 这种VCI技术提供了冠状动脉干预的非侵入性术前评估.
- 该模型显示了优化PCI规划的潜力.
- 这种方法可以提高PCI程序的安全性和效率.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Model Approaches for Pharmacokinetic Data: Physiological Models
109
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
109
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

